tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CASI Stock Latest News

CASI Pharmaceuticals Receives FDA Clearance for CID-103 IND Application
Company AnnouncementsCASI Pharmaceuticals Receives FDA Clearance for CID-103 IND Application
12d ago
6K
CASI
Casi Pharmaceuticals announces FDA clearance of CID-103 IND application
PremiumThe Fly
Casi Pharmaceuticals announces FDA clearance of CID-103 IND application
12d ago
CASI
CASI Pharmaceuticals Appoints David Cory as CEO to Drive CID-103 Program
PremiumCompany Announcements
CASI Pharmaceuticals Appoints David Cory as CEO to Drive CID-103 Program
25d ago
6K
CASI
Casi Pharmaceuticals CEO Wei-Wu He to step down, David Cory to succeed
PremiumThe Fly
Casi Pharmaceuticals CEO Wei-Wu He to step down, David Cory to succeed
26d ago
CASI
Casi Pharmaceuticals to hold a conference call
PremiumThe Fly
Casi Pharmaceuticals to hold a conference call
3M ago
CASI
CASI Pharmaceuticals Schedules Business Update Amid Legal Proceedings
PremiumCompany AnnouncementsCASI Pharmaceuticals Schedules Business Update Amid Legal Proceedings
3M ago
6K
CASI
CASI Pharmaceuticals: Strategic Divestments and Promising Clinical Developments Drive Buy Rating
Premium
Ratings
CASI Pharmaceuticals: Strategic Divestments and Promising Clinical Developments Drive Buy Rating
3M ago
CASI
CASI Pharmaceuticals Reports Q1 2025 Results and Asset Divestiture in China
Premium
Company Announcements
CASI Pharmaceuticals Reports Q1 2025 Results and Asset Divestiture in China
3M ago
6K
CASI
Casi Pharmaceuticals reports Q1 EPS (69c) vs. (71c) last year
PremiumThe Fly
Casi Pharmaceuticals reports Q1 EPS (69c) vs. (71c) last year
3M ago
CASI
CASI Pharmaceuticals Announces CFO Transition
PremiumCompany Announcements
CASI Pharmaceuticals Announces CFO Transition
3M ago
6K
CASI
Casi Pharmaceuticals to divest assets in China
PremiumThe Fly
Casi Pharmaceuticals to divest assets in China
3M ago
CASI
CASI Pharmaceuticals Divests Chinese Assets in $20 Million Deal
PremiumCompany Announcements
CASI Pharmaceuticals Divests Chinese Assets in $20 Million Deal
3M ago
6K
CASI
CASI Pharmaceuticals Faces Nasdaq Compliance Challenge
PremiumCompany AnnouncementsCASI Pharmaceuticals Faces Nasdaq Compliance Challenge
3M ago
6K
CASI
Casi Pharmaceuticals receives Nasdaq deficiency notice
Premium
The Fly
Casi Pharmaceuticals receives Nasdaq deficiency notice
3M ago
CASI
CASI Pharmaceuticals Moves to Arbitration in Dispute with Acrotech
Premium
Company Announcements
CASI Pharmaceuticals Moves to Arbitration in Dispute with Acrotech
4M ago
6K
CASI
Casi Pharmaceuticals price target lowered to $4 from $6 at H.C. Wainwright
PremiumThe Fly
Casi Pharmaceuticals price target lowered to $4 from $6 at H.C. Wainwright
4M ago
CASI
CASI Pharmaceuticals: Strategic Divestment and CID-103 Potential Drive Buy Rating
PremiumRatings
CASI Pharmaceuticals: Strategic Divestment and CID-103 Potential Drive Buy Rating
4M ago
CASI
CASI Pharmaceuticals Acquires Precision Autoimmune Therapeutics
PremiumCompany Announcements
CASI Pharmaceuticals Acquires Precision Autoimmune Therapeutics
4M ago
6K
CASI
CASI Pharmaceuticals Receives Updated Acquisition Proposal for China Operations
PremiumCompany Announcements
CASI Pharmaceuticals Receives Updated Acquisition Proposal for China Operations
5M ago
6K
CASI
CASI Pharmaceuticals receives proposal to acquire China business for $20M
PremiumThe FlyCASI Pharmaceuticals receives proposal to acquire China business for $20M
5M ago
CASI
CASI Pharmaceuticals Reports 2024 Financial Results and Strategic Developments
Premium
Company Announcements
CASI Pharmaceuticals Reports 2024 Financial Results and Strategic Developments
5M ago
6K
CASI
Casi Pharmaceuticals reports Fy24 EPS ($2.56) vs. ($2.02) last year
Premium
The Fly
Casi Pharmaceuticals reports Fy24 EPS ($2.56) vs. ($2.02) last year
5M ago
CASI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >